TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 126 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2017. The put-call ratio across all filers is 9.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,943,073 | -0.6% | 581,890 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $22,069,116 | +470.0% | 581,838 | +265.5% | 0.00% | – |
| Q1 2023 | $3,871,575 | -22.9% | 159,193 | -7.9% | 0.00% | – |
| Q4 2022 | $5,019,884 | -8.0% | 172,861 | -5.0% | 0.00% | – |
| Q3 2022 | $5,456,000 | -10.1% | 182,023 | +8.5% | 0.00% | – |
| Q2 2022 | $6,067,000 | -19.3% | 167,779 | -3.4% | 0.00% | – |
| Q1 2022 | $7,517,000 | -15.6% | 173,766 | -2.2% | 0.00% | – |
| Q4 2021 | $8,903,000 | -19.4% | 177,670 | +2.3% | 0.00% | – |
| Q3 2021 | $11,048,000 | -8.8% | 173,653 | +3.2% | 0.00% | – |
| Q2 2021 | $12,114,000 | -11.7% | 168,330 | -9.5% | 0.00% | – |
| Q1 2021 | $13,719,000 | +23.9% | 186,035 | +23.4% | 0.00% | – |
| Q4 2020 | $11,069,000 | +13911.4% | 150,773 | +10399.5% | 0.00% | – |
| Q3 2020 | $79,000 | +49.1% | 1,436 | +79.1% | 0.00% | – |
| Q2 2020 | $53,000 | +8.2% | 802 | 0.0% | 0.00% | – |
| Q1 2020 | $49,000 | -51.5% | 802 | -29.8% | 0.00% | – |
| Q4 2019 | $101,000 | +17.4% | 1,143 | 0.0% | 0.00% | – |
| Q3 2019 | $86,000 | -12.2% | 1,143 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | -21.0% | 1,143 | 0.0% | 0.00% | – |
| Q1 2019 | $124,000 | -68.2% | 1,143 | -75.2% | 0.00% | – |
| Q4 2018 | $390,000 | -47.5% | 4,608 | -39.0% | 0.00% | – |
| Q3 2018 | $743,000 | +51.9% | 7,559 | +79.1% | 0.00% | – |
| Q2 2018 | $489,000 | -61.6% | 4,221 | -67.2% | 0.00% | – |
| Q1 2018 | $1,272,000 | +34.5% | 12,878 | +42.6% | 0.00% | – |
| Q4 2017 | $946,000 | -98.3% | 9,029 | -98.2% | 0.00% | -100.0% |
| Q3 2017 | $56,028,000 | -0.6% | 497,192 | -1.2% | 0.00% | 0.0% |
| Q2 2017 | $56,375,000 | -3.6% | 503,074 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $58,459,000 | +3915.0% | 501,257 | +3526.5% | 0.00% | +50.0% |
| Q4 2016 | $1,456,000 | +19.6% | 13,822 | +25.4% | 0.00% | 0.0% |
| Q3 2016 | $1,217,000 | -15.7% | 11,023 | +11.2% | 0.00% | 0.0% |
| Q2 2016 | $1,443,000 | +58.4% | 9,911 | +55.8% | 0.00% | +100.0% |
| Q1 2016 | $911,000 | +37.0% | 6,360 | +47.8% | 0.00% | 0.0% |
| Q4 2015 | $665,000 | +1446.5% | 4,303 | +1334.3% | 0.00% | – |
| Q3 2015 | $43,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |